As a professor of pathology and former director of the Medical Automation Research Center at the University of Virginia, Felder has received more than $30 million in grants for his research and development group. He has published more than 260 research papers, has been awarded eight patents and has presented more than 140 lectures in fifteen countries. Felder received his Bachelor of Science degree in chemistry from the College of William and Mary, a Ph.D. in biochemistry from Georgetown University and a post doctorate at the National Institutes of Health.
"Our recipient was instrumental in applying robotics to laboratory automation, one of the most successful non-industrial markets for our technology. Thanks to his [Robin Felder's] pioneering efforts, thousands of lab robots are being used throughout the world today," stated Don Vincent, the past president of the International Federation for Robotics, an affiliate of the RIA.
Felder has also received many Small Technology Transfer Research grants to commercialize robotic innovations. Global Cell Solutions was founded in part on Felder's technology. He has recently incorporated robotics technology into stem cell production for drug discovery and regenerative medicine. "The application of robotics to standardize and streamline cell production will be essential for the success of any regenerative medicine-based company in the near future," explained Felder.
"The life science and medical community has benefited tremendously from Felder's expertise in robotics and automation and this award is well-deserved," said Uday Gupta, President and CEO of Global Cell Solutions. "There is little doubt his efforts have positively impacted modern drug discovery and medicine."
Founded in 1974, RIA represents some 275 member companies including leading robot manufacturers, system integrators, component suppliers, end users, consulting firms, research organizations and universities. For more information visit www.robotics.org.
About Global Cell Solutions
Global Cell Solutions, Inc., headquartered in Charlottesville, Virginia, provides innovative solutions for three-dimensional cell culturing to researchers in biotechnology, drug discovery and therapeutics. The company's products and services, centered on its proprietary GEM (global eukaryotic microcarrier) substrate and BioLevitator automated cell culture system, deliver superior cell quality, survivability and production. For more information, please visit http://www.globalcellsolutions.com.
